Ian H. Paling

Inion Oy is a medical devices company focused on the development and commercialization of innovative biodegradable and bioactive implants for applications in Spine and Specialty Orthopedics applications. By targeting key strategic markets in the USA and select territories in the rest of the world, Inion has built a product portfolio sold through a dedicated network of specialist distributors. Inion's products include biodegradable plates, screws, pins and membranes, which are used to enhance the healing of bone or soft tissue injuries, such as those caused by trauma or by reconstructive surgery. Inion's core expertise is in the design and manufacture of implants from its proprietary Inion Optima™ family of biomaterials, which enables the Company to develop medical implants with properties tailored for specific surgical applications, in terms of strength, flexibility and rate of degradation. Incorporated in 2000, Inion has offices in the UK and USA, and its head office, R&D and manufacturing facilities are in Tampere, Finland.

Sphere Medical Holding Ltd. was engaged in the development of medical monitoring and diagnostic equipment. It focuses on the development of Proxima, which is a platform for measuring blood gases, electrolytes, and metabolites; and Pelorus, which helps in the management of sedation and intravenous anesthesia. The company was founded by Stuart Paul Hendry and Gavin Troughton on March 14, 2001 and was headquartered in London, the United Kingdom.

Metalrax Group Plc manufactures and supplies specialist steel and engineered products and consumer durable products. The company was founded on February 27, 1964 and is headquartered in Birmingham, the United Kingdom.

Corin Group Ltd. develops, manufactures and distributes orthopedic implants. It provides product for hip, knee, and ankle. The company was founded by Peter J. Gibson on May 1, 1985 and is headquartered in Cirencester, the United Kingdom.

Sphere Medical Ltd. develops monitoring and diagnostic products to provide clinical and economic benefits in critical care environment. It offers microfabricated and transducers technologies. The company was founded in March 2002 by Gavin Troughton and is headquartered in Cambridge, the United Kingdom.

CellCoTec Ltd. develops surgery cell-based therapy and biomedical products. Its technology which combines cell interaction with the use of a mechanically functional polymer scaffold in a single surgical intervention. The company was founded by Jens Riesle and Jeanine Heendriks in 2004 and is headquartered in London, the United Kingdom.